the sale of Versatel Deutschland Holding GmbH to Ganymed 345.VV GmbH, a wholly owned subsidiary of Apax Europe VI-A ,L.P. ("Ganymed") has been completed,

Versatel will make an interim distribution out of its freely distributable reserves of EUR 1.391585 per ordinary share in the capital of Versatel. Versatel and Tele2 agreed that Tele2 will be paid its part of the interim distribution by an assignment of the claim against Ganymed arising in connection with the sale of Versatel Deutschland Holding GmbH to Ganymed, all as described in the Offer Memorandum of 14 September 2005. In respect of ordinary shares not tendered in the public offer for the Versatel's ordinary shares, shareholders will receive the amount of EUR 1.391585 per ordinary shares in cash on 17 October 2005 through the admitted institutions (aangesloten instellingen) within the meaning of the Dutch Giro Securities Act (Wet Giraal Effectenverkeer). The ex-date is 17 October 2005;

the resignation of Mr. L.W.A.M. van Doorne, Mr. J. Huber, Mr. L.M.L.H.A. Hermans, Mr. B.L.J.M. Beerkens and Mr. J.G. Drechsel as member of our Supervisory Board has become effective,

the appointment of Mr. J.I. Svedberg, Mr. B.L-J. Jarnheimer, Mr. S.H. Zadler and Mr. M.F. Berglund as member of our Supervisory Board has become effective, and

the deed of amendment to our articles of association has been executed.